|
|
Volumn 305, Issue 17, 2011, Pages 1749-1753
|
|
FDA considers data on potential risks of anesthesia use in infants, children
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANESTHETIC AGENT;
CAFFEINE;
ISOFLURANE;
KETAMINE;
MIDAZOLAM;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NITROUS OXIDE;
OXYGEN;
PROPOFOL;
BRAIN DEVELOPMENT;
CHILD;
COGNITIVE DEFECT;
DISEASE ASSOCIATION;
DRUG POTENTIATION;
DRUG SAFETY;
EMOTIONAL DISORDER;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFANT;
LANGUAGE DISABILITY;
LEARNING DISORDER;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
NERVE CELL NECROSIS;
NERVE DEGENERATION;
NEUROTOXICITY;
NEWBORN;
NONHUMAN;
PEDIATRIC ANESTHESIA;
PEDIATRIC SURGERY;
PRACTICE GUIDELINE;
PRIMATE;
PRIORITY JOURNAL;
RHESUS MONKEY;
RISK ASSESSMENT;
SHORT SURVEY;
SPEECH DISORDER;
|
|
EID: 79955555518
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.546 Document Type: Short Survey |
|
Times cited : (21)
|
|
References (0)
|
